GENEVA, Sept. 7 -- SYNDAX PHARMACEUTICALS, INC. filed a patent application (US2026/017160) for “BENZAMIDE ARYL ETHER ANALOGS COMPRISING A 4,5-SPIRO RING SYSTEM AS INHIBITORS OF THE MENIN-MLL INTERACTION”. With publication no. WO/2026/183524, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 487/10

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....